Serum C-peptide assay of patients with hyperglycemic emergencies at the Lagos State University Teaching Hospital (LASUTH), Ikeja

International Archives of Medicine

Volumn 7, Issue 1, 2014, Pages

  Akinlade, Akinyele Taofiq ^a   Ogbera, Anthonia Okeoghene ^b   Fasanmade, Olufemi Adetola ^c   Olamoyegun, Michael Adeyemi ^d  

^a GENERAL HOSPITAL   (Nigeria)

^b LAGOS STATE UNIVERSITY TEACHING HOSPITAL   (Nigeria)

^c LAGOS UNIVERSITY TEACHING HOSPITAL   (Nigeria)

^d Ladoke Akintola University   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; C PEPTIDE; CREATININE; ELECTROLYTE; GLUCOSE; INSULIN; ORAL ANTIDIABETIC AGENT; POTASSIUM; SODIUM; UREA;

ADOLESCENT; ADULT; AGED; ANION GAP; ARTICLE; ASSAY; BICARBONATE BLOOD LEVEL; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; HYPERGLYCEMIA; HYPERGLYCEMIC EMERGENCY; HYPEROSMOLAR HYPERGLYCEMIC STATE; INFECTION; KETONURIA; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; NORMO OSMOLAR HYPERGLYCEMIC STATE; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PATIENT COMPLIANCE; POTASSIUM BLOOD LEVEL; QUESTIONNAIRE; SERUM OSMOLALITY; SODIUM BLOOD LEVEL; TEACHING HOSPITAL; UNIVERSITY HOSPITAL; UREA BLOOD LEVEL;

EID: 84928574191     PISSN: None     EISSN: 17557682     Source Type: Journal    
DOI: 10.1186/1755-7682-7-50     Document Type: Article

References (120)

1. World Health Organization: Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Report of a WHO Consultation. Geneva: World health organization; 1999.
2. American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care 2006, 29 Suppl 1:S43-S48.
3. Umpierrez GE, Casals MMC, Gebhart SSP, Mixon PS, Clark WS, Phillips LS: Diabetic ketoacidosis in obese African-Americans. Diabetes 1995, 44:790-795. 10.2337/diab.44.7.790
4. Ennis ED, Stahl E, Kreisberg RA: The hyperosmolar hyperglycemic syndrome. Diabetes Rev 1994, 2:115-126.
5. English P, Williams G: Hyperglycaemic crisis and lactic acidosis in diabetes mellitus. Postgrad Med J 2004, 80:253-261. 10.1136/pgmj.2002.004291
6. Leslie RDG, Atkinson MA, Notkins AL: Autoantigens 1A-2 and GAD in type 1 (insulin-dependent) diabetes. Diabetologia 1999, 42:3-14. 10.1007/s001250051105
7. Myers MA, Rabin DU, Rowley MJ: Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylase. Diabetes 1995, 44:1290-1295. 10.2337/diab.44.11.1290
8. Metzger BE, Coustan DR: Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. The Organizing Committee. Diabetes Care 1998, 21 suppl 2:B161-B167.
9. American Diabetes Association: Standards of Medical Care in Diabetes (Position Statement). Diabetes Care 2005,28(Suppl 1):S4-S36.
10. International Federation report on the Internet. In Diabetes Atlas. 2nd edition. Brussels: International Diabetes Federation; 2007. Available at: http://www.eatlas.idf.org/Prevalence/All%5Fdiabetes/
11. Zimmet P: The burden of type 2 diabetes: are we doing enough? Diabetes Metab 2003, 29:659-681.
12. Akinkugbe OO Federal Ministry of Health and Social Services. Final report of the National Expert Committee on Non Communicable Diseases in Nigeria 1997, Series 4:64-90.
13. Osuntokun BO, Akinkugbe FM, Francis TI, Reddy S, Osuntokun O, Taylor GO: Diabetes Mellitus in Nigerians. A study of 832 patients. West Afr Med J 1971,5(20):295-312.
14. Akanji AO, Adetunji A: The pattern of presentation of foot lesions in Nigerian diabetic patients. West Afr J Med 1990, 9:1-4.
15. McMichael AJ, Beaglehole R: The changing global concept of public health. Lancet 2000, 356:495-499. 10.1016/S0140-6736(00)02564-2
16. Remuzzi G, Schippati A, Ruggenenti P: Nephropathy in patients with type 2 diabetes. N Engl J Med 2002, 346:1145-1151. 10.1056/NEJMcp011773
17. Alebiosu BO: Clinical diabetic nephropathy in a tropical African population. West Afr J Med 2003, 22:152-155.
18. National Diabetes Facts Sheet. American Diabetes AssociationAvailable at:. Accessed Jan 2006 http://www.diabetes.org/diabetes-statistics/national-diabetes-fact-sheet.jsp
19. Wilson BE, Sharma A: Public cost and access to primary care for hyperglycemic emergencies, Clark County, Nevada. J Comm Health 1995,20(3):249-256. 10.1007/BF02260408
20. Ogbera AO, Chinenye S, Onyekwere A, Fasanmade O: Prognostic Indices of Diabetes mortality. Ethn Dis 2007, 17:721-725.
21. Anumah F, Ohwovoriole A: Serum biochemistry in Nigerians with hyperglycemic emergencies. Ethn Dis 2008, 18:26-30.
22. Graves EJ, Gillium BS: Detailed diagnosis and procedures: National Discharge Survey, 1995. National Center for Health Statistics. Vital Health Stat 1997, 13:133.
23. Newton CA, Philip R: Diabetes Ketoacidosis in type 1 and type 2 diabetes mellitus. Arch Intern Med 2004, 164:1925-1931. 10.1001/archinte.164.17.1925
24. Ahmed AM, Ahmed NH, Abdella ME: Pattern of hospital mortality among diabetic patients in Sudan. Pract Diabetes Int 2000, 17:41-44.
25. Corrigan CB, Ahren B: Ten years experience of a diabetic clinic in northern Tanzania. East Afr Med J 1968, 45:89-90.
26. Lutalo SKK, Mubongo N: Some clinical and epidemiological aspects of diabetes mellitus in an endemic disease register in Zimbabwe. East Afr Med J 1985, 62:433-445.
27. Rolfe M, Ephraim GG, Lincoln DC, Huddle KR: Hyperosmolar non-ketotic diabetic coma as a cause of emergency hyperglycemic admission to Baragwanath Hospital. S Afr Med J 1995,85(3):173-176.
28. Khan SA, Khan LA: Presentation and outcome of diabetic ketoacidosis in Nigerians. S Arabia Diab Int 2000, 10:50-51.
29. Umpierrez GE, Kelly JP, Navarrete JE, Casals MM, Kitabchi AE: Hyperglycemic crises in urban blacks. Arch Intern Med 1997, 157:669-675. 10.1001/archinte.1997.00440270117011
30. Sakakura C, Hagiwara A, Kin S, Yamamoto K, Okamoto K, Yamaguchi T, Sawai K, Yamagishi H: A case of hyperosmolar nonketotic coma occurring during chemotherapy using cisplatin for gallbladder cancer. Hepatogastroenterol 1999, 46:2801-2803.
31. Kitabchi AE, Umpierrez GE, Murphy MB, Kreisberg RA: Hyperglycemic crises in adult patients with diabetes. A consensus statement from the American Diabetes Association. Diabetes Care 2006, 29:2739-2748. 10.2337/dc06-9916
32. Oli JM, Adeyemo AA, Okafor GO, Ofoegbu EN, Onyenekwe B, Chukwuka CJ, Chen G, Chen Y, Doumatey AP, Aje TO, Rotimi CN: Beta cell function and response to treatment in Nigerians with type 2 diabetes mellitus. Diabetes Res Clin Pract 2004, 69:196-204.
33. Zouvanis M, Pieterse AC, Seftel HC, Joffe BI: Clinical characteristics and outcome of hyperglycaemic emergencies in Johannesburg Africans. Diab Med 1997, 14:603-606.
34. Ashok B, John WZ, David JH, Valory P: New profiles of diabetic ketoacidosis. Type 1 Vs Type 2 diabetes and the effect of ethnicity. Arch Intern Med 1999, 159:2317-2322.
35. American Diabetes Association: Hyperglycemic crisis in patients with diabetes mellitus (position statement). Diabetes Care 2001, 24:154-161.
36. Matz R: Hypothermia in diabetic acidosis. Hormones 1972, 3:36-41. 10.1159/000178256
37. Campbell IW, Duncan LJ, Innes JA, MacCuish AC, Munro JF: Abdominal pain in diabetic metabolic decompensation: clinical significance. JAMA 1975, 233:166-168. 10.1001/jama.1975.03260020052026
38. Wachtel TJ, Silliman RA, Lamberton P: Prognostic factors in the diabetic hyperosmolar state. J Am Geriatr Soc 1978, 35:737-741.
39. Newcomer JW: Second generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs 2005, 19:1-93. 10.2165/00023210-200519010-00001
40. Lorber D: Nonketotic hypertonicity in diabetes mellitus. Med Clin North Am 1995, 79:39-52.
41. Kaminska ES, Pourmoabbed G: Spurious laboratory values in diabetic ketoacidosis and hyperlipidaemia. Am J Emerg Med 1993, 11:77-80. 10.1016/0735-6757(93)90066-K
42. Rumbak MJ, Hughes TA, Kitabchi AE: Pseudonormoglycaemia in diabetic ketoacidosis with elevated triglycerides. Am J Emerg Med 1991, 9:61-63.
43. Adrogue HJ, Lederer ED, Suki WN, Eknoyan G: Determinants of plasma potassium levels in diabetic ketoacidosis. Medicine 1986, 65:163-171.
44. Atchley DW, Loeb RF, Richards DW, Benedict EM, Driscoll ME: A detailed study of electrolyte balance following withdrawal and reestablishment of insulin therapy. J Clin Invest 1933, 12:297-321. 10.1172/JCI100504
45. Gerard SK, Rhayam-Bashi H: Characterization of creatinine error in ketotic patients: a prospective comparison of alkaline picrate methods with an enzymatic method. Am J Clin Pathol 1985, 84:659-661.
46. Yildiz M, Gul L, Ozbay G: Hyperosmolar hyperglycemic nonketotic coma associated with acute myocardial infarction: report of three cases. Acta Cardiol 2002, 57:271-274. 10.2143/AC.57.4.2005425
47. Levetan CS, Passaro MD, Jablonski KA, Ratner RE: Effect of physician specialty on outcomes in diabetic ketoacidosis. Diabetes Care 1999, 22:1790-1795. 10.2337/diacare.22.11.1790
48. Polonsky WH, Anderson BJ, Lohrer PA, Aponte JE, Jacobson AM, Cole CF: Insulin omission in women with IDDM. Diabetes Care 1994, 17:1178-1185. 10.2337/diacare.17.10.1178
49. Banerji MA, Chaiken RL, Huey H, Tuomi T, Norin AJ, Mackay IR, Rowley MJ, Zimmet PZ, Lebovitz HE: GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4: Flatbush diabetes. Diabetes 1994, 43:741-745. 10.2337/diab.43.6.741
50. Ramlo-Halsted BA, Edelman SV: The Natural History of Type 2 Diabetes. Clin Diab 2000, 18:1-16.
51. Kahn SE: The importance of the beta cell in the pathogenesis of type 2 Diabetes Mellitus. Am J Med 2000, 108:2S-8S.
52. Leahy JL: Natural history of β cell dysfunction in NIDDM. Diabetes Care 1990, 13:992-1010. 10.2337/diacare.13.9.992
53. O'Rahilly S, Turner RC, Matthews DR: Impaired pulsatile secretion of insulin in relatives of patients with NIDDM. N Engl J Med 1988, 318:1225-1230. 10.1056/NEJM198805123181902
54. Kjems LL, Volund A, Madsbad S: Quantification of beta-cell function during IVGTT in Type 2 and non-diabetic subjects: assessment of insulin secretion by mathematical methods. Diabetologia 2001, 44:1339-1348. 10.1007/s001250100639
55. Steffes MW, Sibley S, Jackson M, Thomas W: Beta-cell function and the development of diabetes-related complications in the diabetes control and complication trial. Diabetes Care 2003, 26:832-836. 10.2337/diacare.26.3.832
56. Nishiki M, Kurioka S, Yamane Y, Mori T, Yamamoto M, Shimuzu T, Kato Y: Determination of serum C-peptide (CPR) and urinary excretion of CPR as an indicator for introducing intensive insulin treatment in patients with diabetes mellitus. Shimane J Med Sci 2001, 2:25-28.
57. Grant BJ, Barlow E, Miles DW: Plasma C-peptide levels identify insulin-treated diabetic patients suitable for oral hypoglycaemic therapy. Diabet Med 1984, 1:284-286. 10.1111/j.1464-5491.1984.tb01974.x
58. Sinnatammby CS: The Pancreas. In LAST's Anatomy. 10th edition. Edited by: Churchill Livingstone. London: Churchill Livingstone; 1999:260-263.
59. Lal G, Clark OH: The Endocrine Pancreas. International Edition. In Greenspan's Basic and Clincal Endocrinology. 8th edition. (Lange Medical Books). McGraw Hill Medical; 2007:927.
60. Dittrich HM, Hahn von Dorsche H: The pancreas research from the discovery of islets (1869) till the discovery of pancreas - diabetes (1889). Anat Anz 1978, 143:231-241.
61. Bishop AE, Polak JM: The Anatomy, Organization And Ultra Structure Of The Islets Of Langerhans. In Textbook of Diabetes. 3rd edition. Edited by: Pickup JC, Williams G. Oxford: Blackwell Science Ltd; 2003:10.1-10.16.
62. Rhodes CJ, Shoelson S, Halban PA: Insulin Biosynthesis, Processing And Chemistry. In Joslin's Diabetes Mellitus. 14th edition. Edited by: Kahn CR, Weir GC, King GL. Philadelphia: Linppincott Williams and Wilkins company; 2005:65-76.
63. Van Schanftingen E: Short-term regulation of glucokinase. Diabetologia 1994, 37:543-547. 10.1007/BF00403371
64. Cerasi E, Luft R, Efendic S: Decreased sensitivity of the pancreatic beta cells to glucose in pre diabetic and diabetic subjects. A glucose dose response study. Diabetes 1972, 21:224-234. 10.2337/diab.21.4.224
65. Sharp GWG: The adenylate cyclase-cyclic AMP system in the islets of Langerhans and its role in the control of insulin release. Diabetologia 1979, 16:287-296. 10.1007/BF01223617
66. Lebovitz HE: Insulin Resistance and the Insulin Resistance Syndrome. In Clinician's manual on Insulin Resistance. Edited by: Wheatcroft C. London: Science Press Ltd; 2002:1-15.
67. Gill RS, Wood SP: The Structure And Phylogeny Of Insulin. In Textbook of Diabetes. 3rd edition. Edited by: Pickup JC, Williams G. Oxford: Blackwell Science Ltd; 2003:12.1-12.15.
68. Bolli GB, Di Marchi RD, Park GD: Insulin analogues and their potential in the management of diabetes mellitus. Diabetologia 1999, 33:1151-1167.
69. Van Haefen T, Pimenta N, Mitrakon A, Korytkowski A, Jenssen T, Yki-Jarvinen H, Gerich JE: Relative contributions of beta-cell function and tissue insulin sensitivity to fasting and post-glucose load glycemia. Metabolism 2000, 49:1318-1325. 10.1053/meta.2000.9526
70. Palmer JP, Fleming GA, Greenbaum CJ, Herold KC, Jansa LD, Kolb H, Lachin JM, Polonsky KS, Pozzilli P, Skyler JS, Steffes MW: C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve β - cell function. Report of an ADA Workshop, 21-22 October 2001. Diabetes 2004, 53:250-264. 10.2337/diabetes.53.1.250
71. Ashley JP, Frier BM: Circulating C-peptide: measurement and clinical application. Ann Clin Biochem 1981, 18:125. 10.1177/000456328101800301
72. Wahren J, Jornvall H: C-peptide makes a comeback. Diabetes Metab Res Rev 2003, 19:345-347. 10.1002/dmrr.403
73. Johansson JW, Wallberg-Henriksson H, Linde B, Fernqvist-Forbes E, Zierath JR: C-peptide revisited-new physiological effects and therapeutic implications. J Intern Med 1996, 240:115-124. 10.1046/j.1365-2796.1996.19841000.x
74. Johansson BL, Borg K, Fernqvist-Forbes E, Odergren T, Remahl S, Wahren J: C-peptide improves autonomic nerve function in IDDM patients. Diabetologia 1996, 39:687-695. 10.1007/BF00418540
75. Joffe BI, Panz VR, Wing JR, Raal FJ, Seftel HC: Pathogenesis of non-insulin-dependent diabetes mellitus in the Black population of Southern Africa. Lancet 1992, 340:460-462. 10.1016/0140-6736(92)91777-6
76. Rheeder P, Stolk RP, Grobbee DE: Ethnic differences in C-peptide levels and anti-GAD antibodies in South African patients with diabetic ketoacidosis. Q J Med 2001, 94:39-43. http://qjmed.oxfordjournals.org/cgi/content/full/94/1/39-FN1 10.1093/qjmed/94.1.39
77. Bakari AG: Insulinopenic indices among type 2 Diabetic Nigerians. Int J Diab Metab 2005, 13:167-169.
78. Kahn SE: The Importance of β-cell failure in the development and progression of Type 2 Diabetes. J Clin Endocrinol Metab 2001, 86:4047-4058.
79. Pratley R, Weyer C: The role of impaired early insulin secretion in the pathogenesis of type 2 diabetes mellitus. Diabetologia 2001, 44:929-945. 10.1007/s001250100580
80. Polonsky KS, Struris J, Bell G: Non-insulin-dependent diabetes mellitus: a genetically programmed failure of the ß-cell to compensate for insulin resistance. N Engl J Med 1996, 334:777-783. 10.1056/NEJM199603213341207
81. De Fronzo R: The triumvirate ß-cell, muscle, and liver: collusion responsible to NIDDM. Diabetes 1988, 37:667-687. 10.2337/diab.37.6.667
82. UK Prospective Diabetes Study Group: UK prospective diabetes study 16. Overview of 6 years therapy of type 2 diabetes: a progressive disease. Diabetes 1995, 44:1248-1258.
83. Yki-Jarvinen H: Glucose toxicity. Endocr Rev 1992, 13:415-431.
84. Poitout V, Robertson R: Mini-review: secondary beta cell failure in type 2 diabetes - a convergence of glucotoxicity and lipotoxicity. Endocrinology 2002, 143:339-342.
85. Kahn BB, Jeffrey SF: Obesity and insulin Resistance. J Clin Invest 2000, 106:473-481. 10.1172/JCI10842
86. Pinkney J: Clinical Research Methods In Diabetes. In Textbook of Diabetes. 3rd edition. Edited by: Pickup JC, Williams G. Oxford UK: Blackwell Science Ltd; 2003:35.1-35.19.
87. Wallace TM, Levy JC, Matthews DR: Use and abuse of HOMA modeling. Diabetes Care 2004, 27:1487-1495. 10.2337/diacare.27.6.1487
88. Scheen AJ, Castillo MJ, Lefebvre PJ: Assesment of residual insulin secretion in diabetic patients using the intravenous glucagon stimulatory test: methodological aspects and clinical applications (Review). Diabetes Metab 1996, 22:397-406.
89. Sriraj ES, Reddy SSK, Scerbaum WA, Abdulkadir J, Hammel JP, Faiman C: Basal and Postglucagon C peptide levels in Ethiopians with diabetes. Diabetes Care 2002, 25:453-457. 10.2337/diacare.25.3.453
90. Cretti A, Lehtovirta M, Borona E, Brunato B, Zenti MG, Caputo M, Caruso B, Groop LC, Muggeo M, Bonadonna RC: Assessment of beta cell function during the oral glucose tolerance test by minimal model of insulin secretion. J Clin Invest 2001, 31:405-416. 10.1046/j.1365-2362.2001.00827.x
91. Matthews DR: Insulin resistance and beta cell function- a clinical perspective. Diab Obes Metab 2001, 3:28-32.
92. Yudkin JS: Circulating proinsulin -like molecules. J Diabetes Complications 1993, 7:113-123. 10.1016/1056-8727(93)90036-X
93. Ryan EA, Paty BW, Senior PA, Lakey JRT, Bigam D, Shapiro AMJ: Beta score. An assessment of beta cell function after islet transplantation. Diabetes Care 2005, 28:343-347. 10.2337/diacare.28.2.343
94. Bella AF, Adelaja C, Alo J, Adetuyibi A: Insulin secretory reserve in diabetic Nigerian Africans. Afr J Med 1990, 19:39-42.
95. Abutu HO: Beta Cell Function In Insulin Treated Nigerian Diabetic Patients. A Dissertation Submitted To The National Postgraduate Medical College Of Nigeria In Part Fulfillment Of The Requirements For The Fellowship Of The College In Internal Medicine. 1998.
96. Bakari AG, Onyemelukwe GC: Pancreatic beta cell function in type 2 diabetic Nigerian patients. Diabetes Inter 2006, 14:21-23.
97. Osa A: Intravenous Glucose Tolerance in First-Degree Relatives of Patients with Insulin Dependent Diabetes Mellitus. Dissertation Submitted to the National Postgraduate Medical College of Nigeria in Part Fulfillment of the Requirements for the Award of the Fellowship of the College of Internal Medicine. 1996.
98. Osuntokun BO, Ladipo G, Francis TJ: Insulin Resistance in diabetes Mellitus in the African; a misnormer. Ghana Med J 1970, 2:259-263.
99. VanderMerwe MT, Crowther NJ, Schalaphoff GP, Gray IP, Joffe BI, Lönnroth PN: Evidence for insulin resistance in black women from South Africa. Int J Obes Relat Metab Disord 2000, 24:1340-1346. 10.1038/sj.ijo.0801416
100. Osei K, Cottrel DA, Adejuwon CA, Ezenwaka EC, Akanji AO, O'Dorisio TM: Serum insulin and glucose concentrations in people at risk for type 2 diabetes. A comparative study of African Americans and Nigerians. Diabetes Care 1993, 16:1367-1375. 10.2337/diacare.16.10.1367
101. Fasanmade OA: A Study Of Insulin Sensitivity In Selected Nigerian Subjects. Dissertation Submitted To The West African College Of Physicians In Part Fulfillment Of The Requirements Of The Award Of The Fellowship Of The College In Internal Medicine. 1996.
102. WHO Technical Report Series-854: Physical Status: The Use and Interpretation of Anthropometry. Geneva: WHO; 1995.
103. Teasdale G, Jennet B: Assessment of coma and impaired consciousness. A practical scale. Lancet 1974,3; 2(7872):81-84.
104. Trinder P: Determination of blood glucose using 4-Aminohenzone as oxygen acceptor. Ann Clin Biochem 1969, 22:26.
105. Report of the expert committee on the diagnosis and classification of diabetes mellitus Diabetes Care 1997, 20:1183-1197.
106. Fischbach FT: A Manual of Laboratory and Diagnostic Tests. 7th edition. Philadelphia; Lippincott: Williams and Wilkins; 2003:21.
107. Aro A: Role of plasma c- peptide determination in the management of type 2 diabetes. Acta Endocrinol 1985, 272:79-82.
108. Ogbera AO, Awobusuyi J, Unachukwu C, Fasanmade O: Clinical features, predictive factors and outcome of hyperglycemic emergencies in a developing country. BMC Endocr Disord 2009, 9:9. 10.1186/1472-6823-9-9
109. Chu CH, Lee JK, Lam HC, Lu CC: Prognostic factors of hyperglyaemic Hyperosmolar nonketotic state. Chang Gung Med J 2001, 24:345-351.
110. Chung ST, Perue GG, Johnson A, Younger N, Hoo CS, Pascoe RW: Predictors of hyperglycaemic crisis and their associated mortality in Jamaica. Diabetes Res Clin Pract 2006, 73:184-190. 10.1016/j.diabres.2006.01.004
111. MacIsaac RJ, Lee LY, McNeil KJ, Tsalamandris C, Jerums G: Influence of age on the presentation and outcome of acidotic and Hyperosmolar diabetic emergencies. Intern Med J 2002, 32:379-395. 10.1046/j.1445-5994.2002.00255.x
112. Mbugua PK, Otieno CF, Kayima JK, Amayo AA, McLigeyo MB: Diabetic ketoacidosis: clinical presentation and precipitating factors at Kenyatta National Hospital, Nairobi. East Afr Med J 2005, 82:S197-S203.
113. Jabbar A, Farooqui K, Habib A, Islam N, Haque N, Akhter J: Clinical characteristics and outcomes of diabetic ketoacidosis in Pakistani adults with type 2 diabetes mellitus. Diabet Med 2004, 21:920-923. 10.1111/j.1464-5491.2004.01249.x
114. Kitabchi AE, Umpierrez GE, Murphy MB, Barrett EJ, Kreisberg RA, Malone JI, Wall BM: Management of hyperglycemic crises in patients with diabetes mellitus (Technical Review). Diabetes Care 2001, 24:131-153. 10.2337/diacare.24.1.131
115. Ennis ED, Kreisberg RA: Diabetic Ketoacidosis And Hyperosmolar Hyperglycemic State. In Diabetes Mellitus. Edited by: LeRoith D, Taylor SI, Olefsky JM. Philadelphia, Pa: Lippincott-Raven Publishers; 1996:276-286.
116. Assadi FK, John EG, Formell L, Rosenthal IM: Falsely elevated serum creatinine concentration in ketoacidosis. J Pediatr 1985, 107:562-564. 10.1016/S0022-3476(85)80021-4
117. American Diabetes Association: Clinical Practice Recommendations. Diabetes Care 2002,25(suppl 1):51-147.
118. Banerji MA, Levobitz H: Insulin sensitive and insulin resistant variants in NIDDM. Diabetes 1989, 38:784-792. 10.2337/diab.38.6.784
119. Buse JB, Polonsky KS, Burant CF: Insulin Secretion In Type 2 Diabetes Mellitus. In William's Textbook of Endocrinology. 11th edition. Edited by: Saunders Elsevier. Philadelphia: Saunders Elsevier; 2008:1353-1355.
120. Sarlund H, Laakso M, Pyorala K, Pentilla L: Fasting, postprandial and postprandial plus glucagon-stimulated plasma C-peptide levels in non-insulin-dependent diabetics and in control subjects. Acta Med Scand 1987, 221:377-383.